Therapeutic efficacy of transarterial chemo-embolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma

doi:10.3748/wjg.v19.i14.2242

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 14

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5238)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

312

HTML

2735

Figures (1-2)

194

Tables (1-3)

218

Sum=3459

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1069

Download

709

Sum=1778

Apr 14, 2013 (publication date) through Nov 23, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Apr 14, 2013; 19(14): 2242-2248
Published online Apr 14, 2013. doi: 10.3748/wjg.v19.i14.2242

Table 1 Baseline characteristics of the 262 patients

Characteristics
Enrolled patients		262
Age (yr)	Median (range)	70 (32-92)
Sex	Male/female	176/86
Etiology	HBV/HCV/NBNC	30/170/62
Child Pugh classification	A/B/C	147/93/22
Number of tumors	< 10/≥ 10	114/148
Maximum tumor size (mm)	Median (range)	32.5 (8.0-300.0)
Stage¹	I/II/III/IV	17/45/136/64
PVTT grade	Vp0/Vp1-2/Vp3	202/27/33
Total bilirubin (mg/dL)	mean ± SD	1.0 ± 0.7
Albumin (g/dL)	mean ± SD	3.4 ± 0.6
Prothrombin time (%)	mean ± SD	91.1 ± 8.4
Platelet count (× 10⁴/L)	mean ± SD	8.9 ± 5.0
AFP (ng/mL)	median (range)	31.6 (1.0-1 000 000)
AFP-L3 (ng/mL)	median (range)	4.0 (0-91.8)
DCP (mAU/mL)	median (range)	60 (0-928 900)
Previous treatment	Yes/no	107/155

Data are expressed as median values with ranges, mean ± SD, or number of patients.

¹According to the modified RECIST (mRECIST) criteria. HBV: Hepatitis B virus; HCV: Hepatitis C virus; NBNC: Negative for hepatitis B surface antigen and HCV antibody; PVTT: Portal vein tumor thrombosis; AFP: α-fetoprotein; AFP-L3: Lens culinaris agglutinin-reactive fraction of α-fetoprotein; DCP: Des-γ-carboxy prothrombin.

Citation: Kasai K, Ushio A, Kasai Y, Sawara K, Miyamoto Y, Oikawa K, Takikawa Y, Suzuki K. Therapeutic efficacy of transarterial chemo-embolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma. World J Gastroenterol 2013; 19(14): 2242-2248
URL: https://www.wjgnet.com/1007-9327/full/v19/i14/2242.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i14.2242